QCI — Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder Class II

FDA Device Classification

Classification Details

Product Code
QCI
Device Class
Class II
Regulation Number
882.5802
Submission Type
Review Panel
NE
Medical Specialty
Neurology
Implant
No

Definition

External device that uses magnetic fields to induce neural activity in the cerebral cortex to treat neurological and psychiatric disorders and conditions. It is not intended for applying or focusing magnetic fields towards brain areas outside cerebral cortex (e.g., cerebellum).

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K243459brain ultimateUltimate rTMS for OCD (M-series)April 17, 2025
K230657btl industriesBTL-99-OCFebruary 1, 2024
K233742teleemgCloudTMS Edge for OCDDecember 22, 2023
K231350neuroneticsOCD MT Cap (85-00397-000)June 8, 2023
K221129teleemgCloudTMS for OCDMarch 10, 2023
K212289neuroneticsNeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced TMay 6, 2022
K193006tonica elektronikMagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy systemAugust 9, 2020
K183303brainswayBrainsway Deep TMS SystemMarch 8, 2019
DEN170078brainwaysBrainsway Deep Transcranial Magnetic Stimulation (DTMS) SystemAugust 17, 2018